Journal
ONCOIMMUNOLOGY
Volume 3, Issue 9, Pages -Publisher
LANDES BIOSCIENCE
DOI: 10.4161/21624011.2014.954956
Keywords
BRAF; immune checkpoint; PD-1; PD-L1; melanoma
Categories
Ask authors/readers for more resources
Significant advances in the treatment of melanoma have been made with BRAF-targeted therapy and immune checkpoint blockade, and these strategies are now being combined empirically in clinical trials. Potential synergy is demonstrated in murine models and in analysis of longitudinal biopsies from patients on trial, however important questions remain regarding toxicity, optimal timing and sequence of therapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available